Cite Filings / HQL / 0001104659-23-104131

Feed Companies Filings Check

Sign in

POS EX

Post-effective Amendment

abrdn Life Sciences Investors Filed 2023-09-27 Acc 0001104659-23-104131

Documents 1

POS EX Post-effective Amendment , tm2326781d2_posex.htm

Around this filing

2023-10-04 DEFA14A Proxy Materials
2023-10-02 DEFA14A Proxy Materials
2023-09-27 POS EX Post-effective Amendment
2023-09-25 4 President bought 10,096 shares at $12.39 ($125,116)
2023-09-20 4 President bought 12,000 shares at $12.68 ($152,206)
2022-07-29 POS EX Post-effective Amendment

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2326781d2_posex.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…